SEARCH

SEARCH BY CITATION

References

  • Al-Rousan, R.M., Rice, K.M., Katta, A., Laurino, J., Walker, E.M., Wu, M., Triest, W.E. & Blough, E.R. (2011) Deferasirox protects against iron-induced hepatic injury in Mongolian gerbil. Translational Research: the journal of laboratory and clinical medicine, 157, 368377.
  • Darbari, D.S., Kple-Faget, P., Kwagyan, J., Rana, S., Gordeuk, V.R. & Castro, O. (2006) Circumstances of death in adult sickle cell disease patients. American Journal of Hematology, 81, 858863.
  • Deugnier, Y., Turlin, B., Ropert, M., Cappellini, M.D., Porter, J.B., Giannone, V., Zhang, Y., Griffel, L. & Brissot, P. (2011) Improvement in liver pathology of patients with beta-thalassemia treated with deferasirox for at least 3 years. Gastroenterology, 141, 12021211.
  • Manci, E.A., Culberson, D.E., Yang, Y.M., Gardner, T.M., Powell, R., Haynes, Jr, J., Shah, A.K. & Mankad, V.N. (2003) Causes of death in sickle cell disease: an autopsy study. British Journal of Haematology, 123, 359365.
  • Perronne, V., Roberts-Harewood, M., Bachir, D., Roudot-Thoraval, F., Delord, J.M., Thuret, I., Schaeffer, A., Davies, S.C., Galactéros, F. & Godeau, B. (2002) Patterns of mortality in sickle cell disease in adults in France and England. The Hematology Journal: the official journal of the European Haematology Association/EHA, 3, 5660.
  • Sato, T., Kobune, M., Murase, K., Kado, Y., Okamoto, T., Tanaka, S., Kikuchi, S., Nagashima, H., Kawano, Y., Takada, K., Iyama, S., Miyanishi, K., Sato, Y., Takimoto, R. & Kato, J. (2011) Iron chelator deferasirox rescued mice from Fas-induced fulminant hepatitis. Hepatology Research: the official journal of the Japan Society of Hepatology, 41, 660667.
  • 8Vichinsky, E, Bernaudin, F, Forni, GL, Gardner, R, Hassell, K, Heeney, MM, Inusa, B, Kutlar, A, Lane, P, Mathias, L, Porter, J, Tebbi, C, Wilson, F, Griffel, L, Deng, W, Giannone, V & Coates, T. (2011) Long-term safety and efficacy of deferasirox (Exjade) for up to 5 years in transfusional iron-overloaded patients with sickle cell disease. British Journal of Haematology, 154, 38797.